First Manhattan’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-24,577
| Closed | -$66.4K | – | 704 |
|
|
2024
Q3 | $66.4K | Hold |
24,577
| – | – | ﹤0.01% | 672 |
|
|
2024
Q2 | $76.2K | Hold |
24,577
| – | – | ﹤0.01% | 654 |
|
|
2024
Q1 | $112K | Sell |
24,577
-3,201
| -12% | -$14.5K | ﹤0.01% | 753 |
|
|
2023
Q4 | $191K | Hold |
27,778
| – | – | ﹤0.01% | 649 |
|
|
2023
Q3 | $175K | Hold |
27,778
| – | – | ﹤0.01% | 674 |
|
|
2023
Q2 | $231K | Hold |
27,778
| – | – | ﹤0.01% | 634 |
|
|
2023
Q1 | $122K | Buy |
+27,778
| New | +$122K | ﹤0.01% | 769 |
|